Together, these data suggest that TYMS-AAb, IGFBP5-AAb, and HAPLN1-AAb are associated with CMT malignancy, and TYMS-AAb and IGFBP5-AAb are also associated with CMT progression. This evidence concerns the gene TYMS and Charcot-Marie-Tooth disease.